Adaptive seamless design for establishing pharmacokinetics and efficacy equivalence in developing biosimilars

Ryuji Uozumi, Chikuma Hamada

Recently, numerous pharmaceutical sponsors have expressed a great deal of interest in the development of biosimilars, which requires clinical trials to demonstrate the equivalence…